|
|
|
Insider
Information: |
Ingram Robert Alexander |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
516,452 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,790,380 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
516,452 |
|
|
Total
Value |
$5,790,380 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
Percentage
Gain/Loss : |
-59.5%
|
33.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
Director |
2015-05-15 |
32,367 |
2004-05-13 |
0 |
Premium* |
|
Lowes Companies Inc |
LOW |
Director |
2010-05-27 |
0 |
2005-05-27 |
0 |
Premium* |
|
Wolfspeed |
WOLF |
Director |
2018-10-17 |
77,710 |
2008-12-29 |
0 |
Premium* |
|
Bausch Health Companies Inc |
BHC |
Director |
2017-03-31 |
92,046 |
2010-09-28 |
0 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-05-18 |
0 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2015-05-27 |
1,500 |
2015-05-22 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-02-28 |
100,198 |
2016-09-01 |
0 |
Premium* |
|
Novan, Inc. |
NOVN |
Director |
2019-05-22 |
169,777 |
|
0 |
Premium* |
|
Black Diamond Therapeutics, Inc. |
BDTX |
|
2022-12-16 |
42,854 |
2020-09-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2023-02-28 |
4 |
A |
$8.85 |
$19,992 |
D/D |
2,259 |
100,198 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
FORMER DIRECTOR |
|
2022-12-16 |
4 |
A |
$1.50 |
$14,063 |
D/D |
9,375 |
42,854 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-11-30 |
4 |
A |
$13.36 |
$20,000 |
D/D |
1,497 |
97,939 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
|
|
2022-09-16 |
4 |
A |
$2.62 |
$17,250 |
D/D |
6,584 |
33,479 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-08-31 |
4 |
A |
$13.90 |
$19,988 |
D/D |
1,438 |
96,442 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
|
|
2022-06-17 |
4 |
A |
$2.03 |
$17,251 |
D/D |
8,498 |
26,895 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-05-31 |
4 |
A |
$9.31 |
$19,346 |
D/D |
2,078 |
82,138 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
|
|
2022-03-18 |
4 |
A |
$3.02 |
$17,501 |
D/D |
5,795 |
18,397 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2022-02-28 |
4 |
A |
$16.61 |
$18,736 |
D/D |
1,128 |
80,060 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
|
|
2021-12-17 |
4 |
A |
$5.31 |
$17,502 |
D/D |
3,296 |
12,602 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
|
|
2021-09-17 |
4 |
A |
$9.90 |
$18,503 |
D/D |
1,869 |
9,306 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-08-31 |
4 |
A |
$15.92 |
$18,738 |
D/D |
1,177 |
77,378 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2021-06-18 |
4 |
A |
$12.95 |
$16,252 |
D/D |
1,255 |
7,437 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-05-28 |
4 |
A |
$15.77 |
$18,735 |
D/D |
1,188 |
76,201 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2021-03-18 |
4 |
A |
$24.01 |
$16,255 |
D/D |
677 |
6,182 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-02-26 |
4 |
A |
$10.78 |
$18,746 |
D/D |
1,739 |
75,013 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-12-15 |
4 |
A |
$34.29 |
$17,316 |
D/D |
505 |
5,505 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-11-30 |
4 |
A |
$5.11 |
$18,749 |
D/D |
3,669 |
73,274 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-09-30 |
4 |
B |
$30.46 |
$152,285 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-08-31 |
4 |
A |
$4.15 |
$18,750 |
D/D |
4,518 |
69,605 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-06-01 |
4 |
A |
$4.50 |
$18,749 |
D/D |
4,171 |
65,087 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-03-01 |
4 |
A |
$3.00 |
$18,750 |
D/D |
6,250 |
60,916 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-12-01 |
4 |
A |
$2.85 |
$18,747 |
D/D |
6,578 |
54,666 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-11-18 |
4 |
B |
$1.45 |
$29,000 |
D/D |
20,000 |
48,088 |
2.39 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-09-01 |
4 |
A |
$2.99 |
$18,747 |
D/D |
6,270 |
28,088 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|